Comorbid Control Is The Key To Ending The Pandemic

Covid Illustration/Photo: Pixabay

JAKARTA - Public Health Expert from the University of Indonesia Pandu Riono said controlling comorbid or congenital diseases is one of the determining factors for ending the COVID-19 pandemic. a virtual dialogue followed from YouTube Internet Sehat in Jakarta, Friday, February 25. He said kidney disease, cancer, hypertension, and diabetes for years resulted in the bankruptcy of BPJS Kesehatan because it triggered substantial subsidies for patient care. According to Pandu, this situation This is an neglected signal that Indonesia is facing a "Non-Communicable Disease" (NCD). During the COVID-19 pandemic, he said, comorbidities caused deaths due to infectious diseases. When viewed based on the proportion of COVID-19 deaths, he said based on comorbid status, he said, was dominated by people who had I have more than one inherited disease. "The more comorbidities, the higher the risk of death," he said. There were four types of comorbidities studied from March 1, 2021 to February 16, 2022, namely kidney failure which occupies the highest risk of death around 42.3 percent, heart disease 27.8 percent, Diabetes Mellitus was 25.2 percent, and hypertension was 17.8 percent. 40 percent of comorbidities. Pandu encourages strong regulations to control raw materials for food products that have the potential to trigger more severe comorbid symptoms. Pandu, who is also an epidemiologist, said that comorbidities have become a burden on health services in Indonesia, so early detection efforts are needed in order to reduce the risk of treatment in hospitals. health facilities.